自贡锂产业优势在于卤水提锂 近日，一则关于和邦生物（SH603077，股价2.36元，市值208.42亿元）的"小作文"在网络上传播，其中 提到，和邦生物可能投资了15亿元碳酸锂（氢氧化锂）项目。《每日经济新闻》记者核实发现，该项目 并非和邦生物投资，而是和邦生物控股股东的决策。 该项目的签约时间在12月1日，当日，和邦生物股价涨停。该项目地点在四川省自贡市富顺县，相较于 遂宁、德阳等布局较早的锂电区域，自贡的优势则是卤水提锂。 和邦生物未投资15亿元锂盐项目 上述"小作文"显示，和邦富顺碳酸锂（氢氧化锂）项目（通常表述为"碳酸锂/氢氧化锂项目"）总投资 额15亿元，地点在四川省自贡市富顺县。根据名称判断，投资方很可能涉及和邦生物。 和邦生物是一家以化工为主业的大型企业，近年来正积极向光伏玻璃、锂电材料等新能源领域战略转 型。其中还分析了和邦生物的战略选择——"对于和邦生物这样的传统化工巨头而言，进军锂电材料是 其寻求第二增长曲线、实现产业升级的关键一步"。不过，12月5日，和邦生物股价盘中未有异动。 记者核实发现，"自贡观察""富顺融媒"等平台确实在12月3日刊发了一篇文章——《投资15亿元！和邦 富顺碳酸 ...

Group 1 - The core viewpoint of the article is that Jiangyan Group (601065) has successfully launched its lithium extraction project, which is expected to produce 200 tons of lithium carbonate annually after reaching full production [1] - The company's future production capacity will be determined based on market demand [1]

格隆汇11月26日丨江盐集团(601065.SH)在投资者互动平台表示，现阶段公司卤水提锂项目顺利投产后 预计可年产200吨碳酸锂，未来产能规划将根据市场需求来确定。 ...

Group 1 - The company primarily produces potassium chloride and lithium carbonate, positioning itself as a leader in potassium chloride production in China with an annual capacity of 5 million tons [2] - The company plays a crucial role in ensuring the supply of potassium fertilizer, thereby supporting agricultural stability and national food security [2] - In the renewable energy sector, the company leverages its lithium resources to provide strong support for the stable development of the industry, maintaining its leading position in domestic brine lithium extraction with an established capacity of 40,000 tons per year for lithium carbonate [2] Group 2 - The company is actively pursuing a "going out" strategy to expand its acquisition of potassium and lithium mineral resources both domestically and internationally [2] - There is a focus on extending the layout in both upstream and downstream segments of the industry chain, as well as enhancing the high-end segments of the value chain [2]